Insights On Pharmaceutical Production
-
Mitigating Early Development Risks With Samsung Biologics DEVELOPICK™ Platform
6/5/2024
This presentation addresses the critical need for high-throughput, reliable analytical development strategies to support expedited Investigational New Drug (IND) applications.
-
Enhance Your Downstream T-Cell Processing
3/4/2025
T-cell therapies, including CAR-T and TCR, revolutionize cancer treatment by harnessing the immune system. Explore an efficient and scalable production process that helps meet crucial demand.
-
Achieving Speed And Scale With Optimized Synthesis Solutions
11/15/2023
Realize optimal coupling efficiency and increase your productivity for oligonucleotide drugs by selecting the right synthesizer and prioritizing automation to define and tweak synthesis methods.
-
Adapting To Demand: The Importance Of Flexibility In HPAPI Small-Batch Manufacturing
1/27/2025
Watch as experts provide insight into the challenges of HPAPI manufacturing and offer proven strategies for achieving the flexibility required for small-batch production.
-
Building Better Degraders: Targeted Protein Degradation Partners
3/1/2024
Learn from industry experts about the latest advances in chemical building blocks for protein degradation, including warheads, linkers, and ligands, and their role in constructing superior degrades.
-
Producer Cell Line For Large-Scale Viral Vector Manufacturing
3/6/2024
Embrace the future of gene therapies and overcome challenges in large-scale viral vector manufacturing with a one-step process that ensures robustness and scalability.
-
Compatible Platforms For Microbial Identification
11/21/2023
Reduce the time-to-results for microbial identification by taking advantage of the shorter run cycle and off-instrument data analysis provided by this optimized and validated workflow.
-
Tips For Viral Vector Production
4/16/2024
Learn about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements.
-
Biopharma Manufacturing For Advanced Therapies: A Panel Discussion
9/1/2023
Explore highlights from a panel discussion focused on improving biomanufacturing processes to help ensure the next generation of advanced therapies is both accessible and affordable to patients.
-
Next-Gen Biomanufacturing: Process Intensification For mAb Production
6/13/2025
Intensified processes, omics-driven media, and advanced bioreactors can boost efficiency and scalability in mAb production.